Association of PM2.5 Air Pollution with Inflammatory Biomarkers in Patients with Heart Failure
Abstract Body (Do not enter title and authors here): Background: Ambient fine particulate matter (PM2.5) air pollution is associated with inflammatory conditions in the lungs, heart, and circulation. Inflammation may be causal in poor health outcomes, especially for people with existing disease. This study evaluated the association PM2.5 levels with concentrations of 115 plasma inflammatory proteins. Methods: Patients with heart failure (HF) with preserved ejection fraction (HFpEF, n=44) and HF-free controls (n=35) from the Intermountain INSPIRE registry (NCT02450006) were tested for 115 targeted proteins (EMD Millipore and ELISA). HFpEF cases and controls were stratified by ambient PM2.5 levels for low (PM2.5 ≤7 µg/m3) and higher exposure (PM2.5 >20 µg/m3). PM2.5 levels on the day of sample collection were evaluated, as well as 3-day and 7-day PM2.5 moving averages (mAvg) of the concurrent day plus 2 or 6 immediately previous days. Samples drawn on days with PM2.5 = 7.1-20.0 µg/m3 were excluded. Results: Patients with HFpEF averaged 74.6±11.7 years of age (2.8 years since HF diagnosis) and 65.9% were female (controls: 72.0±8.7 years, 62.9% female). In HFpEF cases (Table), PM2.5 >20 µg/m3 on the sample collection day was associated with higher IL-18 (p<0.001 vs. ≤7 µg/m3) and C-C motif chemokine ligand 27 [CCL27, also known as cutaneous T cell-attracting chemokine (CTACK)] (p<0.001 vs. ≤7 µg/m3), with a trend for TNF-α (p=0.012). The 3-day PM2.5 mAvg was significant for IL-18 and CCL27, while CCL27 remained significant for the 7-day mAvg (Table). In controls, none of the 115 biomarkers differed based on PM2.5 levels. Age did not differ in cases or controls by PM2.5 category. Conclusions: In a pilot study evaluating the inflammatory response to air pollution, CCL27 and IL-18 were higher in patients with HFpEF during short-term PM2.5 elevations. Inflammatory biomarkers were not different based on PM2.5 levels in people free of HF. Short-term PM2.5 elevations may induce inflammation and these findings suggest that people with HFpEF struggle to restore homeostasis.
Horne, Benjamin
( Intermountain Heart Inst; Stanford
, Salt Lake City
, Utah
, United States
)
Knight, Stacey
( INTERMOUNTAIN HEALTH CARE
, Salt Lake City
, Utah
, United States
)
Nadeau, Kari
( Harvard School of Public Health
, Boston
, Massachusetts
, United States
)
Knowlton, Kirk
( Intermountain Medical Center
, Salt Lake Cty
, Utah
, United States
)
Haddad, Francois
( Stanford University
, Palo Alto
, California
, United States
)
Anderson, Jeffrey
( INTERMOUNTAIN MEDICAL CENTER
, Murray
, Utah
, United States
)
Maecker, Holden
( Stanford University
, Stanford
, California
, United States
)
Bair, Tami
( INTERMOUNTAIN MEDICAL CENTER
, Murray
, Utah
, United States
)
Johnson, Mary
( Harvard University
, Boston
, Massachusetts
, United States
)
Bride, Daniel
( Intermountain Healthcare
, Murray
, Utah
, United States
)
Muhlestein, Joseph
( INTERMOUNTAIN MEDICAL CTR
, Murray
, Utah
, United States
)
Kim, Juyong
( STANFORD UNIVERSITY
, Stanford
, California
, United States
)
Author Disclosures:
Benjamin Horne:DO have relevant financial relationships
;
Independent Contractor:Pfizer:Past (completed)
; Advisor:Unleash Health:Active (exists now)
| Stacey Knight:DO NOT have relevant financial relationships
| Kari Nadeau:DO have relevant financial relationships
;
Individual Stocks/Stock Options:IgGenix, ,,,:Active (exists now)
; Other (please indicate in the box next to the company name):IgGenix (co-founder):Active (exists now)
; Other (please indicate in the box next to the company name):Latitude (co-founder):Active (exists now)
; Other (please indicate in the box next to the company name):Alladapt (co-founder):Active (exists now)
; Consultant:IgGenix:Active (exists now)
; Consultant:Regeneron:Active (exists now)
; Consultant:Red tree ventures,:Active (exists now)
; Consultant:Excellergy:Active (exists now)
; Individual Stocks/Stock Options:Alladapt:Active (exists now)
; Individual Stocks/Stock Options:Cour:Active (exists now)
; Individual Stocks/Stock Options:ClostraBio:Active (exists now)
; Individual Stocks/Stock Options:Seed Health:Active (exists now)
| Kirk Knowlton:DO NOT have relevant financial relationships
| Francois Haddad:No Answer
| Jeffrey Anderson:DO NOT have relevant financial relationships
| Holden Maecker:DO have relevant financial relationships
;
Advisor:Caris Life Sciences:Active (exists now)
| Tami Bair:DO NOT have relevant financial relationships
| Mary Johnson:No Answer
| Daniel Bride:DO NOT have relevant financial relationships
| Joseph Muhlestein:DO NOT have relevant financial relationships
| Juyong Kim:DO NOT have relevant financial relationships